Companies issue new shares for a variety of strategic and operational reasons, not all of which are negative for shareholders. According to DilutionWatch data covering 7,300+ stocks, approximately 40% of share issuances are associated with capital raises for operations, 25% with acquisitions, 20% with employee compensation, and 15% with debt conversion or restructuring. Understanding the motivation behind dilution is essential for distinguishing value-creating issuance from value-destroying issuance.
The most common reason for share issuance is raising capital to fund operations, growth, or debt repayment. For pre-revenue biotech companies, equity issuance is often the only source of funding because they have no revenue to support debt. For growth companies, equity capital avoids the fixed obligations of debt and can be raised quickly through ATM programs or overnight deals. The key question for investors is whether the capital will be deployed productively — a company raising capital to fund a clinical trial with blockbuster potential may be making a value-creating decision despite the dilution.
Acquisitions are another major driver of share issuance. When companies use stock as currency for acquisitions, they issue shares to the target company's shareholders instead of paying cash. The dilution impact depends entirely on whether the acquisition creates value — if the acquired business generates earnings growth that exceeds the dilution cost, shareholders benefit. However, studies consistently show that the majority of acquisitions destroy value for the acquiring company's shareholders.
Stock-based compensation creates ongoing dilution that companies view as a cost of attracting and retaining talent. Technology companies, in particular, use stock grants and options as a significant portion of total compensation. While this dilution is typically gradual, it can be substantial — some large tech companies issue 2-5% of their outstanding shares annually through compensation plans, requiring significant earnings growth just to maintain flat EPS.
The most concerning reason for share issuance is survival — companies that must raise equity capital to avoid bankruptcy or delisting. These issuances often occur at distressed prices, meaning heavy dilution for minimal capital raised. DilutionWatch identifies companies in survival-mode capital raising through its cash runway analysis, and these companies typically receive the highest DilutionScore™ ratings.
Dilution can be positive when the capital raised is invested in projects with returns significantly exceeding the cost of capital. For example, a company raising $50 million to complete a clinical trial for a drug with a multi-billion dollar market opportunity may create far more value than the dilution destroys.
Equity has no fixed repayment obligation and no interest costs, making it less risky for the company (though more costly for existing shareholders). Pre-revenue companies often cannot qualify for debt financing. Some companies also prefer equity to maintain lower leverage ratios.
Evaluate the return on capital from the proposed use of funds versus the dilution cost. If a company raises $100 million through 20% dilution and invests it at a 30% return, the net effect is positive. If the same capital funds ongoing operating losses with no path to profitability, the dilution is destructive. DilutionWatch provides context through its analysis framework.
DilutionWatch monitors 7,300+ stocks for dilution risk in real time. Get the DilutionScore™ for any ticker instantly.
Search DilutionWatch →